Stocks of major drug makers and biotech companies tumbled in the first full day of trading after Donald Trump announced that he wants vaccine skeptic Robert F.
Shares of leading vaccine producers, such as Pfizer and Moderna, experienced notable drops after Robert F. Kennedy Jr. was ...
The dry powder inhaler market is projected to be worth USD 20.83 billion in 2024. The market is likely to reach USD 29.95 ...
Her designs seamlessly blend traditional Ethiopian motifs with modern aesthetics, crafting a narrative of heritage and ...
Guggenheim's Inaugural Healthcare Innovation Conference November 12, 2024 2:00 PM ETCompany ParticipantsEmma Walmsley - Chief ...
Spero Therapeutics ( (SPRO) ) has released its Q3 earnings. Here is a breakdown of the information Spero Therapeutics presented to its ...
President-elect Trump’s decision to nominate Robert F. Kennedy Jr. for Health and Human Services (HHS) secretary will put ...
JS Global analyst Mubashir Anis Naviwala wrote that the KSE-100 surged to a new all-time intra-day high of 95,278, finally breaking through the crucial 95,000 resistance level. The index closed at ...
Vaccine stocks have struggled since RFK Jr.'s appointment to health secretary, with Moderna and Pfizer seeing the deepest ...
The news prompted a sell-off across the industry. In the US, shares in Pfizer sank more than 4% and Moderna were roughly 9% ...
The inability of COVID vaccines to reach the long-lived plasma cell compartment in the bone marrow may explain their waning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback